NR4A1 and breast neoplasm: Triple-negative breast cancer (TNBC), an aggressive subtype of breast tumor that lacks hormone receptor expression and HER2 gene amplification, accounts for 12%–18% of breast neoplasms (Foulkes et al., 2010).